Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 3—March 2008
Dispatch

Ciprofloxacin-Resistant Salmonella enterica Serotype Typhimurium, China

Shenghui Cui*, Jingyun Li*, Ziyong Sun†, Changqin Hu*, Shaohong Jin*, Yunchang Guo‡, Lu Ran‡, and Yue Ma*Comments to Author 
Author affiliations: *State Food and Drug Administration, Beijing, People’s Republic of China; †Huazhong University of Science and Technology, Wuhan, People’s Republic of China; ‡Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China;

Main Article

Table

Resistance phenotypes of Salmonella enterica serotype Typhimurium
 isolated from Tongji Hospital outpatients, Wuhan, China, May 2002–October 2005

Antimicrobial agent MIC, μg/mL* No. resistant isolates
(n = 44)
Phenicols (chloramphenicol) >32 33
Penicillins
Ampicillin >32 35
Amoxicillin–clavulanic acid >32/16 32
Cephalosporins
Cefepime >32 0
Cefotaxime >64 0
Ceftriaxone >64 0
Tetracyclines (tetracycline) >16 36
Aminoglycosides
Amikacin >64 2
Gentamicin >16 35
Kanamycin >64 15
Streptomycin† NA 40
Sulfonamides and potentiated sulfonamides
Sulfamethoxazole >512 39
Trimethoprim-sulfamethoxazole >4/76 36
Quinolones and fluoroquinolones
Nalidixic acid >32 36
Ciprofloxacin >4 31

*MICs were determined by the broth-microdilution method; results were interpreted in accordance with the interpretive standards of the Clinical and Laboratory Standards Institute (4).
†Resistance to streptomycin was determined by disk-diffusion method. NA, not applied.

Main Article

References
  1. Mead  PS, Slutsker  L, Dietz  V, McCaig  LF, Bresee  JS, Shapiro  C, Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607–25.PubMedGoogle Scholar
  2. Galanis  E, Lo Fo Wong  DM, Patrick  ME, Binsztein  N, Cieslik  A, Chalermchikit  T, Web-based surveillance and global Salmonella distribution, 2000–2002. Emerg Infect Dis. 2006;12:381–8.PubMedGoogle Scholar
  3. Guerrant  RL, Van Gilder  T, Steiner  TS, Thielman  NM, Slutsker  L, Tauxe  RV, Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331–51. DOIPubMedGoogle Scholar
  4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Wayne (PA): The Institute; 2007 (document M100-S17).
  5. Barrett  TJ, Gerner-Smidt  P, Swaminathan  B. Interpretation of pulsed-field gel electrophoresis patterns in foodborne disease investigations and surveillance. Foodborne Pathog Dis. 2006;3:20–31. DOIPubMedGoogle Scholar
  6. Giraud  E, Brisabois  A, Martel  JL, Chaslus-Dancla  E. Comparative studies of mutations in animal isolates and experimental in vitro– and in vivo–selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother. 1999;43:2131–7.PubMedGoogle Scholar
  7. Levesque  C, Piche  L, Larose  C, Roy  PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995;39:185–91.PubMedGoogle Scholar
  8. Ouellette  M, Bissonnette  L, Roy  PH. Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene. Proc Natl Acad Sci U S A. 1987;84:7378–82. DOIPubMedGoogle Scholar
  9. Izumiya  H, Mori  K, Kurazono  T, Yamaguchi  M, Higashide  M, Konishi  N, Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. J Clin Microbiol. 2005;43:5074–9. DOIPubMedGoogle Scholar
  10. Hakanen  A, Kotilainen  P, Huovinen  P, Helenius  H, Siitonen  A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis. 2001;7:996–1003.PubMedGoogle Scholar
  11. Varma  JK, Molbak  K, Barrett  TJ, Beebe  JL, Jones  TF, Rabatsky-Ehr  T, Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis. 2005;191:554–61. DOIPubMedGoogle Scholar
  12. Martin  LJ, Fyfe  M, Dore  K, Buxton  JA, Pollari  F, Henry  B, Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections. J Infect Dis. 2004;189:377–84. DOIPubMedGoogle Scholar
  13. Nyquist  AC, Gonzales  R, Steiner  JF, Sande  MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875–7. DOIPubMedGoogle Scholar

Main Article

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external